1-(2-chlorophenyl)-4-[4-[(3S)-3-ethyl-4-methyl-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl]phenoxy]piperidine
C24H27ClF3N3O — CID 144629872
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2-chlorophenyl)-4-[4-[(3S)-3-ethyl-4-methyl-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl]phenoxy]piperidine
1-(2-chlorophenyl)-4-[4-[(3S)-3-ethyl-4-methyl-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl]phenoxy]piperidine (PubChem CID 144629872) has the molecular formula C24H27ClF3N3O and a molecular weight of 465.95 g/mol. Its IUPAC name is 1-(2-chlorophenyl)-4-[4-[(3S)-3-ethyl-4-methyl-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl]phenoxy]piperidine.
Molecular Properties
| Compound Name | 1-(2-chlorophenyl)-4-[4-[(3S)-3-ethyl-4-methyl-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl]phenoxy]piperidine |
|---|---|
| PubChem CID | 144629872 |
| Molecular Formula | C24H27ClF3N3O |
| Molecular Weight | 465.95 g/mol |
| Exact Mass | 465.18 |
| IUPAC Name | 1-(2-chlorophenyl)-4-[4-[(3S)-3-ethyl-4-methyl-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl]phenoxy]piperidine |
| SMILES | CC[C@H]1C(C)C(C(F)(F)F)=NN1c1ccc(OC2CCN(c3ccccc3Cl)CC2)cc1 |
| InChI | InChI=1S/C24H27ClF3N3O/c1-3-21-16(2)23(24(26,27)28)29-31(21)17-8-10-18(11-9-17)32-19-12-14-30(15-13-19)22-7-5-4-6-20(22)25/h4-11,16,19,21H,3,12-15H2,1-2H3/t16?,21-/m0/s1 |
| InChIKey | FZWKFNCROSSDKX-MRNPHLECSA-N |
| XLogP | 6.54 |
| TPSA | 28.07 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 465.95 |
| LogP ≤ 5 | 6.54 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144629872 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.